ELEVANCE HEALTH INC (1ANTM.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1ANTM - US0367521038 - Common Stock
315.5 EUR
+11.3 (+3.71%)
We assign a fundamental rating of 4 out of 10 to 1ANTM. 1ANTM was compared to 32 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of 1ANTM while its profitability can be described as average. 1ANTM has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
- In the past year 1ANTM was profitable.
- 1ANTM had a positive operating cash flow in the past year.
- Each year in the past 5 years 1ANTM has been profitable.
- 1ANTM had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- 1ANTM's Return On Assets of 4.40% is fine compared to the rest of the industry. 1ANTM outperforms 78.13% of its industry peers.
- 1ANTM has a better Return On Equity (12.26%) than 65.63% of its industry peers.
- 1ANTM has a Return On Invested Capital (5.90%) which is comparable to the rest of the industry.
- Measured over the past 3 years, the Average Return On Invested Capital for 1ANTM is in line with the industry average of 7.02%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.4% | ||
| ROE | 12.26% | ||
| ROIC | 5.9% |
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
1.3 Margins
- With a decent Profit Margin value of 2.83%, 1ANTM is doing good in the industry, outperforming 62.50% of the companies in the same industry.
- 1ANTM's Profit Margin has declined in the last couple of years.
- 1ANTM has a Operating Margin (4.60%) which is in line with its industry peers.
- In the last couple of years the Operating Margin of 1ANTM has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.6% | ||
| PM (TTM) | 2.83% | ||
| GM | N/A |
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 1ANTM is destroying value.
- The number of shares outstanding for 1ANTM has been reduced compared to 1 year ago.
- 1ANTM has less shares outstanding than it did 5 years ago.
- Compared to 1 year ago, 1ANTM has a worse debt to assets ratio.
2.2 Solvency
- The Debt to FCF ratio of 1ANTM is 5.70, which is a neutral value as it means it would take 1ANTM, 5.70 years of fcf income to pay off all of its debts.
- 1ANTM's Debt to FCF ratio of 5.70 is fine compared to the rest of the industry. 1ANTM outperforms 71.88% of its industry peers.
- A Debt/Equity ratio of 0.65 indicates that 1ANTM is somewhat dependend on debt financing.
- 1ANTM's Debt to Equity ratio of 0.65 is amongst the best of the industry. 1ANTM outperforms 84.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 5.7 | ||
| Altman-Z | N/A |
ROIC/WACC0.7
WACC8.37%
2.3 Liquidity
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | N/A | ||
| Quick Ratio | N/A |
3. Growth
3.1 Past
- The earnings per share for 1ANTM have decreased by -6.64% in the last year.
- 1ANTM shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.17% yearly.
- Looking at the last year, 1ANTM shows a quite strong growth in Revenue. The Revenue has grown by 10.21% in the last year.
- Measured over the past years, 1ANTM shows a quite strong growth in Revenue. The Revenue has been growing by 11.14% on average per year.
EPS 1Y (TTM)-6.64%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-12.65%
Revenue 1Y (TTM)10.21%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%14.34%
3.2 Future
- 1ANTM is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.89% yearly.
- The Revenue is expected to grow by 8.96% on average over the next years. This is quite good.
EPS Next Y-8.43%
EPS Next 2Y-2.2%
EPS Next 3Y3%
EPS Next 5Y7.89%
Revenue Next Year12.33%
Revenue Next 2Y8.83%
Revenue Next 3Y7.8%
Revenue Next 5Y8.96%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 11.13, the valuation of 1ANTM can be described as very reasonable.
- Based on the Price/Earnings ratio, 1ANTM is valued cheaply inside the industry as 87.50% of the companies are valued more expensively.
- The average S&P500 Price/Earnings ratio is at 27.54. 1ANTM is valued rather cheaply when compared to this.
- A Price/Forward Earnings ratio of 11.66 indicates a reasonable valuation of 1ANTM.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of 1ANTM indicates a somewhat cheap valuation: 1ANTM is cheaper than 75.00% of the companies listed in the same industry.
- When comparing the Price/Forward Earnings ratio of 1ANTM to the average of the S&P500 Index (24.31), we can say 1ANTM is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.13 | ||
| Fwd PE | 11.66 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1ANTM is on the same level as its industry peers.
- 1ANTM's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.64 | ||
| EV/EBITDA | 10.22 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)1
EPS Next 2Y-2.2%
EPS Next 3Y3%
5. Dividend
5.1 Amount
- 1ANTM has a Yearly Dividend Yield of 1.96%.
- 1ANTM's Dividend Yield is a higher than the industry average which is at 1.57.
- Compared to an average S&P500 Dividend Yield of 1.92, 1ANTM has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.96% |
5.2 History
- On average, the dividend of 1ANTM grows each year by 15.34%, which is quite nice.
Dividend Growth(5Y)15.34%
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
- 1ANTM pays out 28.40% of its income as dividend. This is a sustainable payout ratio.
- The dividend of 1ANTM is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP28.4%
EPS Next 2Y-2.2%
EPS Next 3Y3%
BIT:1ANTM (1/7/2026, 7:00:00 PM)
315.5
+11.3 (+3.71%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)07-17 2025-07-17/bmo
Earnings (Next)10-21 2025-10-21/bmo
Inst Owners93.05%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap71.04B
Revenue(TTM)189.25B
Net Income(TTM)5.36B
Analysts76.43
Price Target317.97 (0.78%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.96% |
Yearly Dividend5.61
Dividend Growth(5Y)15.34%
DP28.4%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.93%
Min EPS beat(2)-2.26%
Max EPS beat(2)4.12%
EPS beat(4)2
Avg EPS beat(4)-3.04%
Min EPS beat(4)-14.2%
Max EPS beat(4)4.12%
EPS beat(8)5
Avg EPS beat(8)-1%
EPS beat(12)8
Avg EPS beat(12)-0.08%
EPS beat(16)11
Avg EPS beat(16)0.72%
Revenue beat(2)2
Avg Revenue beat(2)2.87%
Min Revenue beat(2)1.45%
Max Revenue beat(2)4.3%
Revenue beat(4)3
Avg Revenue beat(4)1.78%
Min Revenue beat(4)-0.71%
Max Revenue beat(4)4.3%
Revenue beat(8)4
Avg Revenue beat(8)0.68%
Revenue beat(12)7
Avg Revenue beat(12)1.06%
Revenue beat(16)10
Avg Revenue beat(16)0.86%
PT rev (1m)-24.27%
PT rev (3m)-34.19%
EPS NQ rev (1m)0.11%
EPS NQ rev (3m)-42.5%
EPS NY rev (1m)-13.11%
EPS NY rev (3m)-12.64%
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)0.55%
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)1.95%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.13 | ||
| Fwd PE | 11.66 | ||
| P/S | 0.44 | ||
| P/FCF | 15.64 | ||
| P/OCF | 12.92 | ||
| P/B | 1.89 | ||
| P/tB | 21.42 | ||
| EV/EBITDA | 10.22 |
EPS(TTM)28.34
EY8.98%
EPS(NY)27.06
Fwd EY8.58%
FCF(TTM)20.17
FCFY6.39%
OCF(TTM)24.43
OCFY7.74%
SpS721.36
BVpS166.65
TBVpS14.73
PEG (NY)N/A
PEG (5Y)1
Graham Number325.98
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.4% | ||
| ROE | 12.26% | ||
| ROCE | 7.72% | ||
| ROIC | 5.9% | ||
| ROICexc | 6.38% | ||
| ROICexgc | 11.77% | ||
| OM | 4.6% | ||
| PM (TTM) | 2.83% | ||
| GM | N/A | ||
| FCFM | 2.8% |
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
ROICexc(3y)7.45%
ROICexc(5y)7.72%
ROICexgc(3y)13.9%
ROICexgc(5y)14.63%
ROCE(3y)9.03%
ROCE(5y)9.4%
ROICexgc growth 3Y-5.49%
ROICexgc growth 5Y-3.16%
ROICexc growth 3Y-5.02%
ROICexc growth 5Y-2.23%
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 5.7 | ||
| Debt/EBITDA | 2.8 | ||
| Cap/Depr | 75.47% | ||
| Cap/Sales | 0.59% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 62.96% | ||
| Profit Quality | 98.73% | ||
| Current Ratio | N/A | ||
| Quick Ratio | N/A | ||
| Altman-Z | N/A |
F-Score5
WACC8.37%
ROIC/WACC0.7
Cap/Depr(3y)77.74%
Cap/Depr(5y)81.03%
Cap/Sales(3y)0.73%
Cap/Sales(5y)0.76%
Profit Quality(3y)103.66%
Profit Quality(5y)128.32%
High Growth Momentum
Growth
EPS 1Y (TTM)-6.64%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-12.65%
EPS Next Y-8.43%
EPS Next 2Y-2.2%
EPS Next 3Y3%
EPS Next 5Y7.89%
Revenue 1Y (TTM)10.21%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%14.34%
Revenue Next Year12.33%
Revenue Next 2Y8.83%
Revenue Next 3Y7.8%
Revenue Next 5Y8.96%
EBIT growth 1Y-14.33%
EBIT growth 3Y0%
EBIT growth 5Y6.19%
EBIT Next Year-1.57%
EBIT Next 3Y2.35%
EBIT Next 5Y8.53%
FCF growth 1Y-49.94%
FCF growth 3Y-14.89%
FCF growth 5Y-2.08%
OCF growth 1Y-45.8%
OCF growth 3Y-11.78%
OCF growth 5Y-1.08%
ELEVANCE HEALTH INC / 1ANTM.MI FAQ
What is the ChartMill fundamental rating of ELEVANCE HEALTH INC (1ANTM.MI) stock?
ChartMill assigns a fundamental rating of 4 / 10 to 1ANTM.MI.
What is the valuation status of ELEVANCE HEALTH INC (1ANTM.MI) stock?
ChartMill assigns a valuation rating of 5 / 10 to ELEVANCE HEALTH INC (1ANTM.MI). This can be considered as Fairly Valued.
How profitable is ELEVANCE HEALTH INC (1ANTM.MI) stock?
ELEVANCE HEALTH INC (1ANTM.MI) has a profitability rating of 4 / 10.
What is the financial health of ELEVANCE HEALTH INC (1ANTM.MI) stock?
The financial health rating of ELEVANCE HEALTH INC (1ANTM.MI) is 3 / 10.
What is the expected EPS growth for ELEVANCE HEALTH INC (1ANTM.MI) stock?
The Earnings per Share (EPS) of ELEVANCE HEALTH INC (1ANTM.MI) is expected to decline by -8.43% in the next year.